Conv. Plasma
Nigella Sativa
Nitric Oxide
Peg.. Lambda

Home   COVID-19 treatment studies for Vitamin D  COVID-19 treatment studies for Vitamin D  C19 studies: Vitamin D  Vitamin D   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Low mortality from COVID-19 at a nursing facility in France following a combined preventive and active treatment protocol
Worcel et al., Annals of Palliative Medicine, doi:10.21037/apm-21-1707
Worcel et al., Low mortality from COVID-19 at a nursing facility in France following a combined preventive and active.., Annals of Palliative Medicine, doi:10.21037/apm-21-1707
Oct 2021   Source   PDF  
  All Studies   Meta
Report on the relatively low mortality and relatively mild COVID-19 symptoms at a French nursing facility that has adopted several treatments including vitamin D, zinc, anticoagulants, corticosteroids, and a multivitamin.
Worcel et al., 12 Oct 2021, peer-reviewed, 5 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Abstract: Original Article Low mortality from COVID-19 at a nursing facility in France following a combined preventive and active treatment protocol Alexandre Worcel1, Bougacha M. Ali1, Sonia Ramos-Pascual2^, Patrick Stirling2, François G. Chary3 1 ELSAN, Clinique Conti, 3 Chemin des Trois Sources, 95290 L'Isle-Adam, France; 2ReSurg SA, Rue Saint-Jean 22, 1260 Nyon, Switzerland; 3 Residence Médicalisée Zemgor, 35 Rue du Martray, 95240 Cormeilles-en-Parisis, France Contributions: (I) Conception and design: All authors; (II) Administrative support: A Worcel, BM Ali, FG Chary; (III) Provision of study materials or patients: A Worcel, BM Ali, FG Chary; (IV) Collection and assembly of data: A Worcel, BM Ali, FG Chary; (V) Data analysis and interpretation: S Ramos-Pascual, P Stirling; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Sonia Ramos-Pascual, MEng, PhD. ReSurg SA, Rue Saint-Jean 22, 1260 Nyon, Switzerland. Email: Background: The aim of this study was to retrospectively describe the evolution of symptoms, infections, and mortality at a nursing facility in France that had implemented a protocol for the prevention and treatment of COVID-19. Methods: A database was created on 21 March 2020 to store all information related to residents, including co-morbidities, as well as COVID-19 symptoms, incidence, and mortality. Residents followed a COVID-19 protocol, consisting of preventive (administering vitamins and zinc, social distancing, and temperature checks) and active (antibiotics, anticoagulants, and corticosteroids) measures. RT-PCR and serology testing were performed on residents. A new coefficient, named the Zemgor coefficient, was calculated as the haemoglobin-to-albumin ratio at 2 time points 15 days apart, to monitor hypoxemia. Results: In January 2020, the nursing facility housed 192 residents, 75 men and 117 women, aged 80±11. One or more co-morbidities were present in 94% of residents, with the most common being dementia. The COVID-19 protocol provided 61% of residents with anticoagulants, 51%with antibiotics, 21% with oxygen therapy, and 3% with corticosteroids. The COVID-19 incidence was 51% based on presence of COVID-19 symptoms, 35% based on positive RT-PCR (amongst residents tested for RT-PCR) and 41% based on positive serology (amongst residents tested for serology), and the COVID-19 mortality rate was 8%. The Zemgor coefficient was 0.049±0.053 for patients with hypoxemia compared to 0.011±0.041 for patients without hypoxemia (P=0.001). Conclusions: The protocol for the prevention and treatment of COVID-19 implemented at this nursing facility resulted in a COVID-19 incidence and mortality at the lower end of that reported by other nursing facilities. Keywords: COVID-19; SARS-COV-2; nursing facility; treatment; mortality Submitted Jun 25, 2021. Accepted for publication Aug 23, 2021. doi: 10.21037/apm-21-1707 View this article at:
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop